A Study to Evaluate Efficacy and Safety of Methacholine Chloride Challenge Test in Diagnosis of Adult Asthma
NCT02100267 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2014-11-17
Summary
The purpose of this study is to evaluate efficacy and safety of Methacholine Chloride challenge test in diagnosis of adult asthma
Conditions
Interventions
- DRUG
-
Methacholine Chloride (SK-1211)
Subjects received saline and 0.039-25 mg/mL of Methacholine chloride
Sponsors & Collaborators
-
Sanwa Kagaku Kenkyusho Co., Ltd.
lead INDUSTRY
Study Design
- Purpose
- DIAGNOSTIC
Eligibility
- Min Age
- 20 Years
- Max Age
- 64 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-04-30
- Primary Completion
- 2014-09-30
- Completion
- 2014-09-30
Countries
- Japan
More Related Trials
-
Single Ascending Dose Study of CM326 in Healthy Volunteers
NCT04842201 ·Status: COMPLETED ·Phase: PHASE1
-
Methacholine Challenge: Comparison of Doubling and Quadrupling Methacholine Dose Regimes Using the Tidal Volume Method
NCT00890539 ·Status: COMPLETED ·Phase: NA
-
A Study to Compare the Relative Potency of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152a to HFA-134a in Mild Asthmatics Aged 18 to 65 Inclusive
NCT06433921 ·Status: RECRUITING ·Phase: PHASE1
-
A Multiple Ascending Doses Study of CM326 Injection in Healthy Subjects
NCT05171348 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial to Assess the Safety, Tolerability and Pharmacokinetics of MDT-637 in Subjects With Intermittent, or Mild-to-Moderate Persistent, Asthma
NCT01556607 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of Single & Repeat Doses of GSK2269557
NCT01462617 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Bronchoprotective Effects of a Single Dose of N6022 in Patients With Mild Asthma
NCT01316315 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of CM310 in Subjects With Moderate to Severe Asthma
NCT05761028 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Phase I Clinical Trial of TQC2731 Injection
NCT04923607 ·Status: UNKNOWN ·Phase: PHASE1
-
Study of Efficacy and Safety of NVA237 in Patients With Poorly Controlled Asthma
NCT02127697 ·Status: WITHDRAWN ·Phase: PHASE3
-
Reversibility of Methacholine Induced Bronchoconstriction
NCT05977699 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-1029 in Participants With Mild to Moderate Asthma
NCT01370317 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of the Safety of ABT-308 in Healthy Volunteers and Subjects With Asthma
NCT00986037 ·Status: COMPLETED ·Phase: PHASE1
-
Study Evaluating the Safety and Effects of MN-221 in Subjects With Moderate to Severe Asthma
NCT00679263 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of MG-K10 in Subjects With Asthma
NCT05382910 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Mannitol Bronchoprovocation Challenge Ancillary Study/ACRN
NCT00585260 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Physiology of Cough in Asthma: Comparison of Sensory-Mechanical Responses to Mannitol and Methacholine Challenge Tests
NCT01064245 ·Status: COMPLETED ·Phase: NA
-
Comparison of Two Methods of Bronchial Methacholine Provocation
NCT00503659 ·Status: COMPLETED ·Phase: NA
-
Study to Investigate the Safety and Efficacy of High Dose of Symbicort® SMART in Japanese Patients
NCT00837967 ·Status: COMPLETED ·Phase: PHASE3
-
Methacholine Challenge Test in School Children With/Without Asthma RISKA
NCT07031102 ·Status: RECRUITING
-
MK0633 Single Dose Study in Japanese Asthmatic Children Aged 12 to Less Than 16 Years (0633-028)
NCT00768170 ·Status: COMPLETED ·Phase: PHASE1
-
Duration of Protective Effect From Inhaled Ipratropium Bromide on Methacholine Airway Hyperresponsiveness
NCT00605410 ·Status: COMPLETED ·Phase: PHASE4
-
Asthma Control, Quality of Life and Emotional Feelings in a Real Life Setting
NCT02640742 ·Status: COMPLETED
-
The Development of a Screening Assay by LC-MS/MS to Monitor Adherence to Asthma Treatment
NCT03460106 ·Status: UNKNOWN
-
Single Dose Study of GSK1440115 in Patients With Asthma
NCT01424280 ·Status: COMPLETED ·Phase: PHASE1